ETON Eton Pharmaceuticals, Inc.

61.15USD-0.33%Mkt Cap: 1.77B USDP/E: 39.84

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap1.77B USD
Enterprise Value1.74B USD
Revenue (TTM)141.06M USD
Gross Profit42.74M USD
Net Income (TTM)-4.60M USD
Revenue/Share5.11 USD
Last Price61.15 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees44
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)39.84
P/E (Forward)18.57
PEG—
EV/EBITDA35.38
EV/Revenue12.32
P/S12.55
P/B20.35
EPS (TTM)1.54 USD
EPS (Forward)3.31 USD
52W Range
14.2783% of range70.64
52W High70.64 USD
52W Low14.27 USD
Profitability
Gross Margin53.46%
Oper. Margin31.30%
EBITDA Margin34.83%
Profit Margin-5.75%
ROE-17.59%
ROA-4.99%
ROIC-2.70%
ROCE-1.57%
Growth
Revenue Growth157.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF10.52M USD
CapEx (TTM)333.00K USD
FCF Margin9.89%
FCF Yield0.79%
Net Debt-31.29M USD
Net Debt/EBITDA-0.64
Net Debt/FCF-2.24
Balance Sheet
Debt/Equity1.19
Current Ratio1.79
Quick Ratio1.52
Book Value/Sh3.02 USD
Cash/Share1.93 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)80.75 USD
Upside (mean)+32.0%
Target Range80.00 USD – 82.00 USD
80.00+32.0% to mean82.00
# Analysts4
Ownership
Shares Out.28.84M
Float22.52M
Insiders4.85%
Institutions78.04%
Short Interest
Short Ratio3.7d
Short % Float9.50%
Short % Out.6.89%
Shares Short1.99M
Short (prev mo.)1.83M
Technical
SMA 5055.52 (+10.1%)
SMA 20038.58 (+58.5%)
Beta0.83
S&P 52W Chg12.00%
Avg Vol (30d)545.45K
Avg Vol (10d)871.44K
Technical Indicators
RSI (14)56.6
MACD2.8195
MACD Signal2.2420
MACD Hist.+0.5775
BB Upper70.85 USD
BB Middle57.08 USD
BB Lower43.31 USD
BB Width48.26%
ATR (14)3.867 USD
Vol Ratio (20d)0.63x

About Eton Pharmaceuticals (NASDAQ: ETON)

›

Eton Pharmaceuticals (NASDAQ: ETON) is listed on Nasdaq, where its shares trade in USD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 44 employees.

The shares were at 61.15 USD on 20 November 2026, up 220.6% over 52 weeks. Its 52-week range is 14.27 USD to 70.64 USD: the price is 13.4% below the high and 328.6% above the low.

At a market capitalisation of 1.77B USD, it trades at 39.8 times trailing earnings and 18.6 times forward earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.5, a premium of 63% for ETON.

Eton Pharmaceuticals reports return on equity of -17.6%, an operating margin of 31.3% and revenue up 157.9% year over year.

It holds more cash than debt, a net cash position of 31.29M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 4 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 80.75 USD is 32.0% above the current price. The next earnings report is expected on 25 March 2027.